Biblio
“Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.”, J Alzheimers Dis, vol. 49, no. 4, pp. 991-1003, 2016.
, “The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-ɛ4 Carriers.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1265-74, 2016.
, “A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1353-63, 2016.
, “Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models.”, J Alzheimers Dis, vol. 53, no. 3, pp. 875-92, 2016.
, “Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1157-76, 2016.
, “Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1183-1192, 2016.
, “The Gesture Imitation in Alzheimer's Disease Dementia and Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1577-84, 2016.
, “Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 145-59, 2016.
, “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.
, “Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data.”, J Alzheimers Dis, vol. 49, no. 2, pp. 571-9, 2016.
, “GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.”, J Alzheimers Dis, vol. 49, no. 2, pp. 365-75, 2016.
, “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.
, “Gypenoside XVII Enhances Lysosome Biogenesis and Autophagy Flux and Accelerates Autophagic Clearance of Amyloid-β through TFEB Activation.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1135-50, 2016.
, “Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1521-1538, 2016.
, “Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.”, J Alzheimers Dis, vol. 51, no. 2, pp. 545-61, 2016.
, “Heart Rate Spectra Confirm the Presence of Autonomic Dysfunction in Dementia Patients.”, J Alzheimers Dis, vol. 54, no. 2, pp. 657-67, 2016.
, “Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 51, no. 2, pp. 333-8, 2016.
, “Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1273-1281, 2016.
, “Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 1, pp. 89-99, 2016.
, “Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 581-90, 2016.
, “Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 49, no. 4, pp. 905-15, 2016.
, “High Risk of Dementia in Ventricular Enlargement with Normal Pressure Hydrocephalus Related Symptoms1.”, J Alzheimers Dis, vol. 52, no. 2, pp. 497-507, 2016.
, “Higher Fasting Plasma Glucose Levels, within the Normal Range, are Associated with Decreased Processing Speed in High Functioning Young Elderly.”, J Alzheimers Dis, vol. 49, no. 3, pp. 589-92, 2016.
, “High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1061-1072, 2016.
, “High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1499-516, 2016.
,